Approvals/CIMA-AEMPS/LEVOSIMENDAN CARINOPHARM 12,5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

LEVOSIMENDAN CARINOPHARM 12,5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Carinopharm Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 094dbff2d95be423
Drug Cima Aemps Name: LEVOSIMENDAN CARINOPHARM 12,5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 86126
Holder Company Name: Carinopharm Gmbh
Marketing Company Name: Carinopharm Gmbh
Authorization Date: 2021-10-08
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 12,5 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Carinopharm Gmbh

LEVOSIMENDAN

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 8, 2021

Approval ID

094dbff2d95be423

Type

Standard